Share This Author
New aspects of the pharmacokinetics and pharmacodynamics of clonidine in man
- D. Arndts, J. Doevendans, R. Kirsten, B. Heintz
- Medicine, BiologyEuropean Journal of Clinical Pharmacology
- 2004
TLDR
Novel potent inhibitor of receptor-activated nonselective cation currents in HL-60 cells.
- D. Krautwurst, J. Hescheler, D. Arndts, W. Lösel, R. Hammer, G. Schultz
- Biology, ChemistryMolecular pharmacology
- 1 May 1993
TLDR
New aspects of the clinical pharmacology of clonidine.
- D. Arndts
- Medicine, BiologyChest
- 1 February 1983
TLDR
Development of a RIA for clonidine and its comparison with the reference methods.
- D. Arndts, H. Stähle, H. Förster
- MedicineJournal of pharmacological methods
- 1 December 1981
A newly developed precise and sensitive radioimmunoassay for clonidine.
TLDR
[Studies on the distribution and elimination of a proteinase inhibitor with isotope technics].
- D. Arndts, K. O. Räker, P. Török, E. Habermann
- ChemistryArzneimittel-Forschung
- 1 May 1970
Evaluation of clonidine plasma levels in man using a highly sensitive radioimmunoassay
Within the past few years the need for safe, sensitive, and specific drug determination methods has become increasingly necessary.
Ω-conotoxin GVIA potently inhibits the currents mediated by P2X receptors in rat DRG neurons
- U. Lalo, Y. Pankratov, D. Arndts, O. Krishtal
- BiologyBrain Research Bulletin
- 15 March 2001
Alinidine pharmacokinetics following acute and chronic dosing.
TLDR
...
...